Case number 1:19-cv-01862
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 12, 2022 | 13 | CONSENT JUDGMENT (CASE CLOSED)Signed by Judge Colm F. Connolly on 12/12/2022. (nmf) (Entered: 12/12/2022) (6) |
| Dec 12, 2022 | 14 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2. (Attachments: # 1 Consent Judgment)(nmf) (Entered: 12/12/2022) (Main Document) (1) |
| Dec 12, 2022 | 14 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2. (Attachments: # 1 Consent Judgment)(nmf) (Entered: 12/12/2022) (Consent Judgment) (6) |
| Dec 9, 2022 | 12 | PROPOSED CONSENT JUDGMENT Between Boehringer and the Aurobindo Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 12/09/2022) (6) |
| Oct 29, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. (fms) |
| Oct 29, 2019 | N/A | Remark (0) Docket Text: All papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 29, 2019 | 11 | SO ORDERED (6) Docket Text: SO ORDERED, re (8 in 1:19-cv-01866-CFC, 8 in 1:19-cv-01865-CFC, 8 in 1:19-cv-01885-CFC, 8 in 1:19-cv-01864-CFC, 127 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01862-CFC) Stipulation. The New Cases shall be consolidated with the Consolidated Action for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). See Stipulations for further details and deadlines. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to ANSWER Complaint to October 30, 2019 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Set/Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 10/30/2019; Aurobindo Pharma USA, Inc. answer due 10/30/2019. Signed by Judge Colm F. Connolly on 10/22/2019. (fms) |
| Oct 22, 2019 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER Complaint to October 30, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Oct 21, 2019 | 9 | Stipulation (6) Docket Text: STIPULATION for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Oct 14, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Aurobindo Pharma Ltd. served on 10/12/2019, answer due 11/4/2019. (Egan, Brian) |
| Oct 14, 2019 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Aurobindo Pharma USA, Inc. served on 10/12/2019, answer due 11/4/2019. (Egan, Brian) |
| Oct 9, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:19-cv-01862-CFC, 1:19-cv-01864-CFC, 1:19-cv-01865-CFC, 1:19-cv-01866-CFC, 1:19-cv-01885-CFC (rjb) |
| Oct 9, 2019 | 6 | Main Document (15) Docket Text: First AMENDED COMPLAINT against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.- filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1)(Egan, Brian) |
| Oct 9, 2019 | 6 | Exhibit 1 (48) |
| Oct 3, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. on 10/3/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mal) |
| Oct 3, 2019 | 1 | Main Document (15) Docket Text: COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2746739.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1, # (2) Civil Cover Sheet)(mal) |
| Oct 3, 2019 | 1 | Exhibit 1 (48) |
| Oct 3, 2019 | 1 | Civil Cover Sheet (1) |
| Oct 3, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Oct 3, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/13/2019. Date of Expiration of Patent: 04/03/2034.Thirty Month Stay Deadline: 2/1/2022. (mal) |
| Oct 3, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2. (mal) |
| Oct 3, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. No for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (mal) |
| Oct 3, 2019 | 1 | Complaint* (1) |
